Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1978 3
1981 1
1983 2
1984 2
1985 4
1986 5
1987 6
1988 9
1989 2
1990 7
1991 3
1992 3
1993 7
1994 9
1995 4
1996 7
1997 4
1998 6
1999 13
2000 7
2001 6
2002 7
2003 12
2004 9
2005 6
2006 10
2007 4
2008 12
2009 18
2010 9
2011 12
2012 15
2013 8
2014 13
2015 9
2016 14
2017 3
2018 8
2019 6
2020 5
2021 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

285 results
Results by year
Filters applied: . Clear all
Page 1
Silent progression in disease activity-free relapsing multiple sclerosis.
University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. University of California, San Francisco MS-EPIC Team, et al. Among authors: goodin ds. Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30. Ann Neurol. 2019. PMID: 30851128 Free PMC article.
Preface.
Goodin DS. Goodin DS. Handb Clin Neurol. 2014;122:ix-x. doi: 10.1016/B978-0-444-52001-2.09984-2. Handb Clin Neurol. 2014. PMID: 24507541 No abstract available.
Long-term evolution of multiple sclerosis disability in the treatment era.
University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL. University of California, San Francisco MS-EPIC Team:, et al. Among authors: goodin ds. Ann Neurol. 2016 Oct;80(4):499-510. doi: 10.1002/ana.24747. Epub 2016 Aug 13. Ann Neurol. 2016. PMID: 27464262 Free PMC article.
Evidence-based medicine.
Goodin DS. Goodin DS. Int MS J. 2005 Nov;12(3):94-5. Int MS J. 2005. PMID: 16422017 Review.
Neuromyelitis optica.
Cree BA, Goodin DS, Hauser SL. Cree BA, et al. Among authors: goodin ds. Semin Neurol. 2002 Jun;22(2):105-22. doi: 10.1055/s-2002-36534. Semin Neurol. 2002. PMID: 12524556 Review.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA, Kappos L, Stites T, Li B, Cappiello L, von Rosenstiel P, Lublin FD. Calabresi PA, et al. Among authors: goodin d. Lancet Neurol. 2014 Jun;13(6):545-56. doi: 10.1016/S1474-4422(14)70049-3. Epub 2014 Mar 28. Lancet Neurol. 2014. PMID: 24685276 Clinical Trial.
Marijuana and multiple sclerosis.
Goodin D. Goodin D. Lancet Neurol. 2004 Feb;3(2):79-80. doi: 10.1016/s1474-4422(03)00655-0. Lancet Neurol. 2004. PMID: 14746994 Review. No abstract available.
Visual evoked potentials.
Aminoff MJ, Goodin DS. Aminoff MJ, et al. Among authors: goodin ds. J Clin Neurophysiol. 1994 Sep;11(5):493-9. doi: 10.1097/00004691-199409000-00004. J Clin Neurophysiol. 1994. PMID: 7844240 Review.
Relapses in multiple sclerosis: Relationship to disability.
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Goodin DS, et al. Mult Scler Relat Disord. 2016 Mar;6:10-20. doi: 10.1016/j.msard.2015.09.002. Epub 2015 Sep 8. Mult Scler Relat Disord. 2016. PMID: 27063617 Review.
285 results